Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
EPIRUS Biopharmaceuticals, Inc.Listing unverified | Other | $6.4M | Unusual size | SEC | |
EPIRUS Biopharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | Unusual size | SEC | |
EPIRUS Biopharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | Unusual size | SEC | |
EPIRUS Biopharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | Unusual size | SEC | |
EPIRUS Biopharmaceuticals, Inc.Listing unverified | Other | $1.8M | Unusual size | SEC | |
EPIRUS Biopharmaceuticals, Inc.Listing unverified | Other | $4.9M | Unusual size | SEC | |
DEXCOM INCListing on record | Sell | $14M | SEC | ||
Capstone Energy Plus, Inc.Listing unverified | Other | $7.4K | SEC | ||
Capstone Energy Plus, Inc.Listing unverified | Other | $6.7K | SEC | ||
Capstone Energy Plus, Inc.Listing unverified | Other | $7.4K | SEC | ||
Capstone Energy Plus, Inc.Listing unverified | Other | $7.4K | SEC | ||
Capstone Energy Plus, Inc.Listing unverified | Other | $7.4K | SEC | ||
Capstone Energy Plus, Inc.Listing unverified | AwardD (derivative) | $15.9K | SEC | ||
Capstone Energy Plus, Inc.Listing unverified | AwardD (derivative) | $18.8K | SEC | ||
ABATIX CORPListing unverified | Buy | $7.8K | conv 83First in 12mo | SEC | |
Capstone Energy Plus, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |